174
Only a small fraction of drugs can cross the blood-brain barrier–the layer that protects the brain from harmful substances. Usually a good thing, it also makes it harder to treat brain cancers, neurological conditions, and nervous system disorders. Now Lantern Pharma, founded in Dallas in 2013, is using an AI-driven tool to improve treatment protocols. And the company’s CEO says this is just the beginning. Details in Dallas Innovates.
